albuterol has been researched along with Long QT Syndrome in 4 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Excerpt | Relevance | Reference |
---|---|---|
"Latent forms of long QT syndrome have been already reported." | 1.30 | [Latent long QT syndrome: discription of a clinical case]. ( Bianconi, L; Castro, A; Pandozi, C; Santini, M; Toscano, S, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aliaga, CA | 1 |
Arizon, LF | 1 |
Bermúdez, RM | 1 |
Castán, JAB | 1 |
Santandreu, AV | 1 |
Williams, C | 1 |
Finn, AF | 1 |
Thompson, CM | 1 |
Banov, CH | 1 |
O'Connor, BK | 1 |
Case, CL | 1 |
Castro, A | 1 |
Pandozi, C | 1 |
Bianconi, L | 1 |
Toscano, S | 1 |
Santini, M | 1 |
4 other studies available for albuterol and Long QT Syndrome
Article | Year |
---|---|
Severe hypokalemia secondary to abuse of β-adrenergic agonists in a pediatric patient: Case report.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Drug Overdose; Factitious Disorders; Humans; Hypoka | 2019 |
Cause of death in the SMART Trial.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Black or African American; Cause of Death; Dose-Respons | 2006 |
Beta2-agonist induced ventricular dysrhythmias secondary to hyperexcitable conduction system in the absence of a long QT syndrome.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Beclomethasone; Child; Electrocardiog | 1997 |
[Latent long QT syndrome: discription of a clinical case].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Electrocardiography; | 1997 |